M. Edgren et al., POSITRON EMISSION TOMOGRAPHY IN THE MANAGEMENT OF METASTATIC RENAL-CELL CARCINOMA, Antibody immunoconjugates, and radiopharmaceuticals, 8(4), 1995, pp. 215-226
Citations number
17
Categorie Soggetti
Immunology,"Radiology,Nuclear Medicine & Medical Imaging
Eleven patients with histopathologically proven advanced renal cell ca
rcinoma were examined with positron emission tomography (PET) utilizin
g L-(methyl)-C-11-methionine; two were also examined with F-18-2-fluor
o-2-deoxy-D-glucose((18)FDG). A total number of 21 PET scans was perfo
rmed, Twenty three lesions were evaluated in these 11 patients. Seven
of the 11 patients had PET scans performed prior to and following ther
apy with IL-2 and IFN. The results obtained on PET scans were correlat
ed to computer tomography (CT) images, We observed that PET technique
utilizing C-11-methionine and (18)FDG can be used for visualization an
d in vivo characterization of renal cell carcinoma metastatses. Our re
sults indicate that PET can also be used to obtain an early assessment
of treatment response.